市場調査レポート

商品コード

創薬アウトソーシングの市場規模、シェア、成長分析、ワークフロー別、治療領域別、地域別 - 産業予測、2024年～2031年

Drug Discovery Outsourcing Market Size, Share, Growth Analysis, By Workflow, By Therapeutics Area, By Region - Industry Forecast 2024-2031

出版日: 2024年10月01日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

創薬アウトソーシングの世界市場規模は、2022年に約34億米ドルと評価され、予測期間（2024-2031年）のCAGRは7.2%で、2023年の36億米ドルから上昇し、2031年には63億米ドルに達すると予測されています。

世界の創薬アウトソーシング市場は、費用対効果が高く効率的な医薬品開発プロセスに対する需要の高まりにより、著しい成長を遂げています。製薬企業は、専門的な知識、高度な技術、拡張可能なリソースを利用するため、アウトソーシングを活用するようになっています。このシフトにより、企業はコアコンピタンスに集中できる一方、運用コストを削減し、創薬のタイムラインを短縮することができます。さらに、医薬品開発の複雑性が増し、規制要件も厳しくなっていることから、企業は革新的なソリューションと包括的なサービスを提供する研究開発業務受託機関（CRO）との提携を進めています。北米や欧州などの調査地域は、大手製薬会社や研究機関の存在により、市場を独占しています。しかし、同市場は、データプライバシーに関する懸念、知的財産の問題、アウトソーシング・パートナーが提供するサービスの質のばらつきといった課題にも直面しており、成長の妨げになる可能性があります。こうした課題にもかかわらず、技術の進歩やバイオテクノロジーへの投資の増加により、市場内に新たな機会が生まれると期待されています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Charles River Laboratories International, Inc.
WuXi AppTec Co., Ltd.
Laboratory Corporation of America Holdings（LabCorp）
Evotec SE
Covance Inc.
Thermo Fisher Scientific Inc.
Eurofins Scientific
Pharmaron Beijing Co., Ltd.
Syngene International Ltd.
Genscript Biotech Corporation
ChemPartner
Jubilant Biosys Ltd.
ICON plc
QuintilesIMS（IQVIA）
Cambrex Corporation
Viva Biotech
Domainex Ltd.
Curia Global, Inc.（formerly Albany Molecular Research, Inc.）
Tecan Group Ltd.
Shanghai Medicilon Inc.

Product Code: SQMIG35C2011

Global Drug Discovery Outsourcing Market size was valued at around 3.4 billion in 2022 and is expected to rise from USD 3.6 billion in 2023 to reach a value of USD 6.3 billion by 2031, at a CAGR of 7.2% over the forecast period (2024-2031).

The Global Drug Discovery Outsourcing Market is witnessing significant growth, driven by an increasing demand for cost-effective and efficient drug development processes. Pharmaceutical companies are increasingly leveraging outsourcing to access specialized expertise, advanced technologies, and scalable resources. This shift allows firms to focus on their core competencies while reducing operational costs and expediting the drug discovery timeline. Additionally, the rising complexity of drug development, coupled with stringent regulatory requirements, is pushing companies to collaborate with Contract Research Organizations (CROs) that offer innovative solutions and comprehensive services. Regions like North America and Europe dominate the market, owing to the presence of major pharmaceutical companies and research institutions. However, the market also faces challenges such as data privacy concerns, intellectual property issues, and the variability in the quality of services provided by outsourcing partners, which could potentially hinder growth. Despite these challenges, advancements in technology and increasing investments in biotech are expected to create new opportunities within the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Outsourcing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Outsourcing Market Segmental Analysis

Global Drug Discovery Outsourcing Market is segmented by Workflow, Therapeutics Area, Drug Type, Service Type, End User, and region. Based on Workflow, the market is segmented into Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, and Other Associated Workflow. Based on Therapeutics Area, the market is segmented into Respiratory system, Pain and Anesthesia, Oncology, Ophthalmology, Hematology, Cardiovascular, Endocrine, Gastrointestinal, Immunomodulation, Anti-infective, Central Nervous System, Dermatology, and Genitourinary System. Based on Drug Type, the market is segmented into Small Molecules, Large Molecules (Biopharmaceuticals). Based on Service Type, the market is segmented into Chemistry Services, Biology Services. Based on End User, the market is segmented into Pharmaceutical & Biotechnology companies, Academic Institutes, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Drug Discovery Outsourcing Market

Technological advancements are a pivotal driver of the Global Drug Discovery Outsourcing Market. The integration of cutting-edge technologies such as artificial intelligence (AI), machine learning, and big data analytics into drug discovery processes has revolutionized the landscape. These technologies enable faster data analysis, predictive modeling, and more accurate identification of potential drug candidates. By outsourcing to firms that specialize in these advanced methodologies, pharmaceutical companies can enhance their research efficiency, reduce time-to-market, and improve the overall success rate of drug development. Furthermore, advancements in automation and high-throughput screening techniques are allowing for more efficient laboratory processes, further supporting the trend toward outsourcing. As the drug discovery process becomes increasingly reliant on these technologies, the demand for specialized outsourcing services is expected to rise, driving market growth.

Restraints in the Global Drug Discovery Outsourcing Market

Data security concerns represent a significant restraint on the Global Drug Discovery Outsourcing Market. As pharmaceutical companies share sensitive research data and proprietary information with outsourcing partners, the risk of data breaches and unauthorized access becomes a pressing issue. Regulatory compliance requirements, such as the Health Insurance Portability and Accountability Act (HIPAA) and the General Data Protection Regulation (GDPR), impose stringent guidelines on data management and protection, complicating outsourcing arrangements. Any breach of confidentiality can lead to significant financial losses, legal repercussions, and reputational damage for pharmaceutical companies. Moreover, varying data protection laws across different countries add to the complexity, making it challenging for firms to ensure compliance. Consequently, companies may hesitate to fully embrace outsourcing, which can limit the market's growth potential.

Market Trends of the Global Drug Discovery Outsourcing Market

The increasing focus on personalized medicine is a notable trend shaping the Global Drug Discovery Outsourcing Market. As the healthcare industry shifts toward tailored treatments based on individual genetic profiles and specific patient needs, drug discovery processes must adapt accordingly. Outsourcing partners are increasingly required to develop innovative methodologies and technologies that facilitate the discovery of targeted therapies. This trend not only enhances the efficacy of drug development but also improves patient outcomes by ensuring that treatments are aligned with unique biological characteristics. The rise of biomarker research, genomic studies, and advanced analytics is driving collaboration between pharmaceutical companies and CROs, who are equipped to handle the complexities associated with personalized medicine. As this trend continues to gain momentum, the demand for specialized outsourcing services that can support the development of personalized therapies is expected to grow, influencing the overall dynamics of the market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Case Study Analysis

Drug Discovery Outsourcing Market, By Workflow

Market Overview
Target Identification & Screening
Target Validation & Functional Informatics
Lead Identification & Candidate Optimization
Preclinical Development
Other Associated Workflow

Drug Discovery Outsourcing Market, By Therapeutics Area

Market Overview
Respiratory system
Pain and Anesthesia
Oncology
Ophthalmology
Hematology
Cardiovascular
Endocrine
Gastrointestinal
Immunomodulation
Anti-infective
Central Nervous System
Dermatology
Genitourinary System

Drug Discovery Outsourcing Market, By Drug Type

Market Overview
Small Molecules
Large Molecules (Biopharmaceuticals)

Drug Discovery Outsourcing Market, By Service Type

Market Overview
Chemistry Services
Biology Services

Drug Discovery Outsourcing Market, By End User

Market Overview
Pharmaceutical & Biotechnology companies
Academic Institutes
Others

Drug Discovery Outsourcing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Charles River Laboratories International, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evotec SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covance Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmaron Beijing Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syngene International Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ChemPartner
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Biosys Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuintilesIMS (IQVIA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cambrex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viva Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Domainex Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curia Global, Inc. (formerly Albany Molecular Research, Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Medicilon Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

創薬アウトソーシングの市場規模、シェア、成長分析、ワークフロー別、治療領域別、地域別 - 産業予測、2024年～2031年

Drug Discovery Outsourcing Market Size, Share, Growth Analysis, By Workflow, By Therapeutics Area, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

創薬アウトソーシング市場：ワークフロー別

創薬アウトソーシング市場：治療領域別

創薬アウトソーシング市場：薬剤タイプ別

創薬アウトソーシング市場：サービスタイプ別

創薬アウトソーシング市場：エンドユーザー別

創薬アウトソーシング市場規模：地域別